BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25378332)

  • 1. Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines.
    Suzuki A; Makinoshima H; Wakaguri H; Esumi H; Sugano S; Kohno T; Tsuchihara K; Suzuki Y
    Nucleic Acids Res; 2014 Dec; 42(22):13557-72. PubMed ID: 25378332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis.
    Kikutake C; Yahara K
    PLoS One; 2016; 11(4):e0152918. PubMed ID: 27042856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenomic enhancer profiling defines a signature of colon cancer.
    Akhtar-Zaidi B; Cowper-Sal-lari R; Corradin O; Saiakhova A; Bartels CF; Balasubramanian D; Myeroff L; Lutterbaugh J; Jarrar A; Kalady MF; Willis J; Moore JH; Tesar PJ; Laframboise T; Markowitz S; Lupien M; Scacheri PC
    Science; 2012 May; 336(6082):736-9. PubMed ID: 22499810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
    Chen H; Lorton B; Gupta V; Shechter D
    Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA Methylation Analysis Reveals
    Niu X; Liu F; Zhou Y; Zhou Z; Zhou D; Wang T; Li Z; Ye X; Yu Y; Weng X; Zhang H; Ye J; Liao M; Liu Y; Chen Z; Lu S
    Clin Cancer Res; 2017 Sep; 23(17):5003-5014. PubMed ID: 28490462
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
    Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
    Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic and epigenomic landscapes during cell fusion in BeWo trophoblast cells.
    Shankar K; Kang P; Zhong Y; Borengasser SJ; Wingfield C; Saben J; Gomez-Acevedo H; Thakali KM
    Placenta; 2015 Dec; 36(12):1342-51. PubMed ID: 26515927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-dimensional, deep-sequencing study of lung adenocarcinoma in female never-smokers.
    Kim SC; Jung Y; Park J; Cho S; Seo C; Kim J; Kim P; Park J; Seo J; Kim J; Park S; Jang I; Kim N; Yang JO; Lee B; Rho K; Jung Y; Keum J; Lee J; Han J; Kang S; Bae S; Choi SJ; Kim S; Lee JE; Kim W; Kim J; Lee S
    PLoS One; 2013; 8(2):e55596. PubMed ID: 23405175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.
    Lenka G; Tsai MH; Lin HC; Hsiao JH; Lee YC; Lu TP; Lee JM; Hsu CP; Lai LC; Chuang EY
    Sci Rep; 2017 Feb; 7():42573. PubMed ID: 28198450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
    Simmonds P; Loomis E; Curry E
    Genome Med; 2017 Jun; 9(1):54. PubMed ID: 28592290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
    Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
    Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide DNA methylation analysis of lung carcinoma reveals one neuroendocrine and four adenocarcinoma epitypes associated with patient outcome.
    Karlsson A; Jönsson M; Lauss M; Brunnström H; Jönsson P; Borg Å; Jönsson G; Ringnér M; Planck M; Staaf J
    Clin Cancer Res; 2014 Dec; 20(23):6127-40. PubMed ID: 25278450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of an integrated allele-specific pipeline for methylomic and epigenomic analysis (MEA).
    Richard Albert J; Koike T; Younesy H; Thompson R; Bogutz AB; Karimi MM; Lorincz MC
    BMC Genomics; 2018 Jun; 19(1):463. PubMed ID: 29907088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide DNA methylome variation in two genetically distinct chicken lines using MethylC-seq.
    Li J; Li R; Wang Y; Hu X; Zhao Y; Li L; Feng C; Gu X; Liang F; Lamont SJ; Hu S; Zhou H; Li N
    BMC Genomics; 2015 Oct; 16():851. PubMed ID: 26497311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide mapping of histone H3 lysine 4 trimethylation in Eucalyptus grandis developing xylem.
    Hussey SG; Mizrachi E; Groover A; Berger DK; Myburg AA
    BMC Plant Biol; 2015 May; 15():117. PubMed ID: 25957781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential regulatory mutations using multi-omics analysis and haplotyping of lung adenocarcinoma cell lines.
    Sereewattanawoot S; Suzuki A; Seki M; Sakamoto Y; Kohno T; Sugano S; Tsuchihara K; Suzuki Y
    Sci Rep; 2018 Mar; 8(1):4926. PubMed ID: 29563587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-cell analysis of lung adenocarcinoma cell lines reveals diverse expression patterns of individual cells invoked by a molecular target drug treatment.
    Suzuki A; Matsushima K; Makinoshima H; Sugano S; Kohno T; Tsuchihara K; Suzuki Y
    Genome Biol; 2015 Apr; 16(1):66. PubMed ID: 25887790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
    Zhang QH; Dai XH; Dai ZM; Cai YN
    Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.